Home / LRRFIP1 Knockout Cell Lines

LRRFIP1 Knockout Cell Lines

Gene: LRRFIP1

Official Full Name: LRR binding FLII interacting protein 1provided by HGNC

Gene Summary: Enables DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and protein homodimerization activity. Involved in negative regulation of transcription by RNA polymerase II. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO33466 LRRFIP1 Knockout cell line (HeLa) Human LRRFIP1 1:3~1:6 Negative Online Inquiry
KO33467 LRRFIP1 Knockout cell line (HCT 116) Human LRRFIP1 1:2~1:4 Negative Online Inquiry
KO33468 LRRFIP1 Knockout cell line (HEK293) Human LRRFIP1 1:3~1:6 Negative Online Inquiry
KO33469 LRRFIP1 Knockout cell line (A549) Human LRRFIP1 1:3~1:4 Negative Online Inquiry

Background

LRRFIP1 Gene Knockout Cell Lines represent an advanced tool in genetic research, specifically designed to facilitate the study of the LRRFIP1 gene's role in various biological processes and disease mechanisms. This product consists of cell lines in which the LRRFIP1 gene has been specifically disrupted using CRISPR-Cas9 technology. By creating these knockout models, researchers can accurately assess the gene's function, enabling the exploration of pathways associated with immune response, inflammation, and tumorigenesis.

The primary function of LRRFIP1 Gene Knockout Cell Lines is to enable the precise investigation of gene-specific signaling pathways and cellular responses. By eliminating the expression of LRRFIP1, these cell lines allow for the examination of downstream effects on critical processes such as NF-κB signaling and cellular stress responses. The ability to manipulate these pathways poses significant implications for understanding complex biological responses and could lead to breakthroughs in therapeutic interventions.

In research and clinical settings, these knockout cell lines serve as invaluable resources for elucidating the biological roles of LRRFIP1. They can be used in high-throughput screening assays, synthetic lethality studies, and drug discovery efforts aimed at targeting specific oncogenic pathways. Such insights are particularly important in the context of cancer therapy, where understanding gene interactions can inform treatment strategies.

What sets LRRFIP1 Gene Knockout Cell Lines apart from alternatives on the market is the meticulous validation and characterization that underpin their development. Each cell line is extensively tested to confirm the complete ablation of gene expression and functionality, providing researchers with reliable and reproducible results. Additionally, the ease of use and compatibility with common laboratory techniques makes these cell lines a practical choice for a wide range of applications.

For researchers and clinicians invested in advancing knowledge of genetic mechanisms, the LRRFIP1 Gene Knockout Cell Lines provide a robust platform for experimentation and discovery. By leveraging these specialized cell lines, users can enhance the precision of their studies, ultimately leading to meaningful advancements in biomedical research.

Our company brings expertise in the development of high-quality biological products tailored to the needs of modern research. We strive to support the scientific community with innovative tools that foster groundbreaking discoveries in genetics and beyond.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.